Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihalis I Panayiotidis

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Cancer Letters|November 5, 2013
Cancer epigenetics as biomarkers of clinical significanceMihalis I Panayiotidis
Mutation Research|April 24, 2009
Environmental toxicity, oxidative stress, human disease and the "black box" of their synergism: how much have we revealed?Rodrigo Franco, Mihalis I Panayiotidis
Chemico-Biological Interactions|June 18, 2010
Cell death or survival: The double-edged sword of environmental and occupational toxicityRodrigo Franco, Mihalis I Panayiotidis
Current Molecular Medicine|February 7, 2012
Biomarkers of oxidative stress and cancer: from chemistry, biology to clinical applications and personalized therapyAlexandros G Georgakilas, Mihalis I Panayiotidis
The Journal of Biological Chemistry|August 29, 2007
Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formationRodrigo Franco, Mihalis I Panayiotidis, John A Cidlowski
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 12, 2020
Combining immune checkpoint inhibitors with denosumab: a new era in repurposing denosumab in oncology?Maria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Expert Review of Clinical Pharmacology|October 19, 2020
Repurposing denosumab in breast cancer beyond prevention of skeletal related events: Could nonclinical data be translated into clinical practice?Maria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Mutation Research|March 23, 2011
Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesisDominique Ziech, Rodrigo Franco, Aglaia Pappa, et al.
Immunotherapy|April 30, 2020
Endocrine adverse events related with immune checkpoint inhibitors: an update for cliniciansMaria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Personalized Medicine|June 27, 2020
Prophylactic lymph node dissection in clinically N0 differentiated thyroid carcinoma: example of personalized treatmentMaria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Cancer Letters|November 5, 2013
Cancer epigenetics as biomarkers of clinical significanceMihalis I Panayiotidis
Mutation Research|April 24, 2009
Environmental toxicity, oxidative stress, human disease and the "black box" of their synergism: how much have we revealed?Rodrigo Franco, Mihalis I Panayiotidis
Chemico-Biological Interactions|June 18, 2010
Cell death or survival: The double-edged sword of environmental and occupational toxicityRodrigo Franco, Mihalis I Panayiotidis
Current Molecular Medicine|February 7, 2012
Biomarkers of oxidative stress and cancer: from chemistry, biology to clinical applications and personalized therapyAlexandros G Georgakilas, Mihalis I Panayiotidis
The Journal of Biological Chemistry|August 29, 2007
Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formationRodrigo Franco, Mihalis I Panayiotidis, John A Cidlowski
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 12, 2020
Combining immune checkpoint inhibitors with denosumab: a new era in repurposing denosumab in oncology?Maria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Expert Review of Clinical Pharmacology|October 19, 2020
Repurposing denosumab in breast cancer beyond prevention of skeletal related events: Could nonclinical data be translated into clinical practice?Maria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Mutation Research|March 23, 2011
Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesisDominique Ziech, Rodrigo Franco, Aglaia Pappa, et al.
Immunotherapy|April 30, 2020
Endocrine adverse events related with immune checkpoint inhibitors: an update for cliniciansMaria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Personalized Medicine|June 27, 2020
Prophylactic lymph node dissection in clinically N0 differentiated thyroid carcinoma: example of personalized treatmentMaria V Deligiorgi, Mihalis I Panayiotidis, Dimitrios T Trafalis
Pageof 14